GNBT News and Press, Generex Biotechnology From 07/29/19

Filing of up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Recording and transcript of shareholders conference call available at www.generex.com MIRAMAR, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ...

Filing up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Spin-out of NuGenerex Immuno-Oncology as a separately-traded public company Merger of NGIO with Kiromic Payoff of notes Recording available at www.generex.com MIRAMAR, Fla., July 26, 2019 (GLOBE NEWSWIR...

MIRAMAR, Fla., July 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its investor conference call, to be hosted by President & Chief Executi...

Retires $3,150,972 in debt and satisfies all associated obligations Payment in GNBT restricted common shares at the July 16, 2019 closing price MIRAMAR, Fla., July 19, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it ha...

- Generex A37 Immunotherapy Vaccine demonstrates high efficacy with low adverse side effects against many common cancers and diseases - Combination Phase II trial with MRK Keytruda and GNBT A37 for Breast Cancer enrolling 2019 - Upfront license payments for AE37 by Shenzhen Bi...

MIRAMAR, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Thursday July 25, 2019 at 4:00 pm to update investors on the company’s plans for the GNBT up-list and t...

Olaregen Silver Sponsorship Dr. Lois Chandler, PhD Presents Excellagen Research as Keynote Speaker at Wound Care Symposium Rapid Acceleration of Healing with Wound Conforming, Native Structural Matrix - New Alternative to Sheet-Based Skin Substitutes MIRAMAR, Fla., July 15, 2019 (...

Medisource Partners is an FDA registered distributor with an extensive portfolio of medical and surgical products including bone grafts and biologics Partnerships and contracts with hospital systems for ordering, billing, and inventory management Generex to complete the acquisition of t...

Pantheon Medical manufactures a line of FDA cleared products used in orthopedic surgeries including screws, plates, implants, and anchors MIRAMAR, Fla., July 11, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that the company has completed...

GNBT Reorganization & Transformation Acquisitions: Olaregen Therapeutix, Regentys, Veneto Assets, Pantheon Medical, MediSource Partners Completed 100% Acquisition of HDS (now NuGenerex Diagnostics) and Retired Associated Debt NuGenerex Immuno-Oncology (NGIO) Formation and Kiromic A...